Fluid therapy in plastic surgery

Evaluation of Goal Directed Fluid Therapy (GDFT) through Pleth Variability Index(PVI) in Plastic Surgery based on Enhanced Recovery After Surgery(ERAS)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210508051226N1

Enrollment

Registered

2022-10-25

Start date

2022-10-22

Completion date

Unknown

Last updated

2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Plastic and cosmetic surgeries such as abdominoplasty, mammoplasty and lift. Other plastic surgery for unacceptable cosmetic appearance

Interventions

Intervention 1: Intervention group:36 patients are done fluid therapy (GDFT) based on PVI index. These patients are hospitalized the night before the operation and will be allowed to consume solid foo

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: With no history of specific diseases that are referred for plastic and cosmetic surgeries such as abdominoplasty, mammoplasty and lift

Exclusion criteria

Exclusion criteria: Surgeries other than cosmetics and plastic surgery Outpatient cosmetic surgeries History of heart disease (cardiac arrhythmia, cardiac ejection fraction =30%) History of lung disease interfering with mechanical ventilation History of chronic kidney failure

Design outcomes

Primary

Measure	Time frame
Comparison of targeted fluid therapy (GDFT) through Plethysmographic Variability Index (PVI) in plastic surgeries based on rapid recovery protocol for patients after surgery (ERAS). Timepoint: during surgery period. Method of measurement: Through plethysmographic variability index (PVI) using pulse oximeter.	—

Secondary

Measure	Time frame
Pain severity. Timepoint: daily after surgery. Method of measurement: Visual Analogue Score.;Post operative nausea and vomiting. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Surgical site infection. Timepoint: Day 1-3-7-28 after surgery. Method of measurement: physician observation.;Drowsiness and fatigue. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Constipation. Timepoint: daily after surgery. Method of measurement: questionnaire.;Renal function. Timepoint: day 1-2 afyter surgery. Method of measurement: measuring serum creatinine.;Pulmonary function. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Desire for early discharge. Timepoint: after surgery. Method of measurement: Questionnaire.;Wound dehiscence. Timepoint: daily after surgery. Method of measurement: physician observation.	—

Measure

Time frame

Pain severity. Timepoint: daily after surgery. Method of measurement: Visual Analogue Score.;Post operative nausea and vomiting. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Surgical site infection. Timepoint: Day 1-3-7-28 after surgery. Method of measurement: physician observation.;Drowsiness and fatigue. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Constipation. Timepoint: daily after surgery. Method of measurement: questionnaire.;Renal function. Timepoint: day 1-2 afyter surgery. Method of measurement: measuring serum creatinine.;Pulmonary function. Timepoint: daily after surgery. Method of measurement: Questionnaire.;Desire for early discharge. Timepoint: after surgery. Method of measurement: Questionnaire.;Wound dehiscence. Timepoint: daily after surgery. Method of measurement: physician observation.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNazli Ebrahimian

Tehran University of Medical Sciences

Nazli.ebrahimian@gmail.com+98 21 6634 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026